GB2569616B - Sustained release oral pharmaceutical compositions of dicycloverine - Google Patents

Sustained release oral pharmaceutical compositions of dicycloverine Download PDF

Info

Publication number: GB2569616B
Authority: GB; United Kingdom
Prior art keywords: dicycloverine; pharmaceutical compositions; sustained release; oral pharmaceutical; release oral
Prior art date: 2017-12-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

GB1721606.0A

Other versions

GB2569616A (en

GB201721606D0 (en

Inventor

Patel Kamlesh

Maganbhai Patel Sanjaykumar

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Syri Ltd

Original Assignee

Syri Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-12-21

Filing date

2017-12-21

Publication date

2020-04-22

2017-12-21 Application filed by Syri Ltd filed Critical Syri Ltd

2017-12-21 Priority to GB1721606.0A priority Critical patent/GB2569616B/en

2018-02-07 Publication of GB201721606D0 publication Critical patent/GB201721606D0/en

2019-06-26 Publication of GB2569616A publication Critical patent/GB2569616A/en

2020-04-22 Application granted granted Critical

2020-04-22 Publication of GB2569616B publication Critical patent/GB2569616B/en

Status Expired - Fee Related legal-status Critical Current

2037-12-21 Anticipated expiration legal-status Critical

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)

GB1721606.0A 2017-12-21 2017-12-21 Sustained release oral pharmaceutical compositions of dicycloverine Expired - Fee Related GB2569616B (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
GB1721606.0A GB2569616B (en)	2017-12-21	2017-12-21	Sustained release oral pharmaceutical compositions of dicycloverine

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB1721606.0A GB2569616B (en)	2017-12-21	2017-12-21	Sustained release oral pharmaceutical compositions of dicycloverine

Publications (3)

Publication Number	Publication Date
GB201721606D0 GB201721606D0 (en)	2018-02-07
GB2569616A GB2569616A (en)	2019-06-26
GB2569616B true GB2569616B (en)	2020-04-22

Family

ID=61131518

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB1721606.0A Expired - Fee Related GB2569616B (en)	2017-12-21	2017-12-21	Sustained release oral pharmaceutical compositions of dicycloverine

Country Status (1)

Country	Link
GB (1)	GB2569616B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003095934A (en) *	2001-09-27	2003-04-03	Kowa Co	Painkillers
MX2013002805A (en) *	2013-03-13	2014-09-17	Miguel Ángel García Pérez	Dual system for treating gastrointestinal diseases.

2017
- 2017-12-21 GB GB1721606.0A patent/GB2569616B/en not_active Expired - Fee Related

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003095934A (en) *	2001-09-27	2003-04-03	Kowa Co	Painkillers
MX2013002805A (en) *	2013-03-13	2014-09-17	Miguel Ángel García Pérez	Dual system for treating gastrointestinal diseases.

Also Published As

Publication number	Publication date
GB2569616A (en)	2019-06-26
GB201721606D0 (en)	2018-02-07

Publication	Publication Date	Title
HK1247822A1 (en)	2018-10-05	Formulations for oral administration of active agents
ZA201908454B (en)	2021-10-27	Solid preparation of cariprazine for oral administration
IL270812A (en)	2020-01-30	Solid compositions for oral administration
IL264880A (en)	2019-04-30	Formulations for oral administration of active agents
HK1248544A1 (en)	2018-10-19	Stable pharmaceutical composition for oral administration
HK1245646A1 (en)	2018-08-31	Pharmaceutical composition for oral administration
IL267279A (en)	2019-08-29	Pharmaceutical formulations of suvorexant
PL3326619T3 (en)	2022-06-06	Solid oral pharmaceutical compositions comprising tenofovir and emtricitabine
EP3506947A4 (en)	2020-06-03	Pharmaceutical formulations of regadenoson
EP3373907A4 (en)	2019-12-18	Sustained release pharmaceutical compositions and methods of use
IL273259A (en)	2020-04-30	Manufacturing of pharmaceutical compositions
IL265662B (en)	2019-11-28	Pharmaceutical compositions of 5-ht6 antagonist
GB2569616B (en)	2020-04-22	Sustained release oral pharmaceutical compositions of dicycloverine
PL3638211T3 (en)	2024-04-15	Delayed sustained release pharmaceutical compositions
HK1232144A1 (en)	2018-01-05	Pharmaceutical composition for oral administration
LT3377044T (en)	2021-11-25	Ibuprofen compositions for direct oral administration
ZA202002086B (en)	2022-12-21	Alcohol-resistant oral pharmaceutical compositions of lorazepam
EP3687539A4 (en)	2021-07-07	Stable pharmaceutical compositions of dalfampridine

Legal Events

Date	Code	Title	Description
2022-08-24	PCNP	Patent ceased through non-payment of renewal fee	Effective date: 20211221